Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies
Elucid , a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding.
- Elucid , a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding.
- The round was led by Elevage Medical Technologies , with additional participation from industry strategics and existing investors.
- This round brings the company’s total funding to $121 million since inception.
- “Elevage believes leading this investment in Elucid is pivotal to support the development and commercialization of its groundbreaking diagnostic tools.